Pharmacokinetics of valerenic acid after single and multiple doses of valerian in older women

Phytotherapy Research

Volumn 24, Issue 10, 2010, Pages 1442-1446

  Anderson, Gail D ^a   Elmer, Gary W ^a   Taibi, Diana M ^a   Vitiello, Michael V ^b   Kantor, Eric ^a   Kalhorn, Thomas F ^a   Howald, William N ^a   Barsness, Suzanne ^b   Landis, Carol A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

pharmacokinetics; valerenic acid; valerian

Indexed keywords

VALERIAN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MAXIMUM PLASMA CONCENTRATION; MULTIPLE CYCLE TREATMENT; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; VALERIANA OFFICINALIS;

AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BODY WEIGHT; FEMALE; HALF-LIFE; HUMANS; HYPNOTICS AND SEDATIVES; INDENES; MIDDLE AGED; OILS, VOLATILE; PHYTOTHERAPY; SESQUITERPENES; SLEEP INITIATION AND MAINTENANCE DISORDERS; VALERIAN;

VALERIANA; VALERIANA OFFICINALIS;

EID: 78649404580     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3151     Document Type: Article

References (13)

1. Anderson GD, Elmer GW, Kantor ED, Templeton IE, Vitiello MV., 2005. Pharmacokinetics of valerenic acid after administration of valerian in healthy subjects. Phytother Res 19: 801-803.
2. Bent S, Padula A, Moore D, Patterson M, Mehling W., 2006. Valerian for sleep: a systematic review and meta-analysis. Am J Med 119: 1005-1012.
3. Blumenthal M., 2006. Total sales of herbal supplements in United States show steady growth. HerbalGram 71: 64-66.
4. Buscemi N, Vandermeer B, Friesen C, et al,. 2007. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med 22: 1335-1350.
5. Hadley S, Petry JJ., 2003. Valerian. Am Fam Physician 67: 1755-1758.
6. Hendriks H, Bos R, Woerdenbag HJ, Koster AS., 1985. Central nervous depressant activity of valerenic acid in the mouse. Planta Med 51: 28-31.
7. Houghton PJ., 1999. The scientific basis for the reputed activity of Valerian. J Pharm Pharmacol 51: 505-512.
8. Ohayon MM., 2002. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 6: 97-111.
9. Taibi DM, Landis CA, Petry H, Vitiello MV., 2007. A systematic review of valerian as a sleep aid: safe but not effective. Sleep Med Rev 11: 209-230.
10. Taibi DM, Vitiello MV, Barsness S, Elmer GW, Anderson GD, Landis CA., 2009. A randomized clinical trial of valerian fails to improve self-reported, polysomnographic, and actigraphic sleep in older women with insomnia. Sleep Med 10: 319-328.
11. Upton R, Graff A, Williamson E, et al,. 1999. Valerian Root. Valeriana officinalis. Analytical Quality Control and Therapeutic Monograph. American Herbal Pharmacopoeia: Santa Cruz.
12. Vitiello MV., 2000. Effective treatment of sleep disturbances in older adults. Clin Cornerstone 2: 16-27.
13. Vitiello MV, Larsen LH, Moe KE, Borson S, Schwartz RS, Prinz PN., 1996. Objective sleep quality of healthy older men and women is differentially disrupted by nighttime periodic blood sampling via indwelling catheter. Sleep 19: 304-311.